The Manufacturers Life Insurance Company reduced its position in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 17.5% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 425,880 shares of the company’s stock after selling 90,120 shares during the quarter. The Manufacturers Life Insurance Company owned 0.85% of Prestige Consumer Healthcare worth $15,621,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in PBH. Huntington National Bank increased its stake in Prestige Consumer Healthcare by 45.4% during the 1st quarter. Huntington National Bank now owns 782 shares of the company’s stock valued at $29,000 after purchasing an additional 244 shares in the last quarter. Advisor Group Holdings Inc. bought a new stake in shares of Prestige Consumer Healthcare in the first quarter worth approximately $62,000. Chevy Chase Trust Holdings Inc. bought a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth approximately $68,000. Islay Capital Management LLC bought a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth approximately $85,000. Finally, Quantbot Technologies LP bought a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth approximately $122,000.

PBH stock opened at $36.63 on Tuesday. Prestige Consumer Healthcare Inc has a one year low of $27.40 and a one year high of $46.12. The company’s fifty day moving average price is $40.62 and its 200-day moving average price is $39.60. The company has a debt-to-equity ratio of 1.50, a quick ratio of 1.67 and a current ratio of 2.44. The company has a market capitalization of $1.85 billion, a PE ratio of 13.18, a price-to-earnings-growth ratio of 3.08 and a beta of 0.80.

Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Thursday, May 7th. The company reported $0.82 EPS for the quarter, topping the consensus estimate of $0.74 by $0.08. The firm had revenue of $251.20 million for the quarter, compared to the consensus estimate of $239.65 million. Prestige Consumer Healthcare had a net margin of 14.77% and a return on equity of 13.33%. The company’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.72 earnings per share. On average, research analysts predict that Prestige Consumer Healthcare Inc will post 2.99 EPS for the current fiscal year.

In related news, CEO Ronald M. Lombardi sold 29,593 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $40.00, for a total transaction of $1,183,720.00. Following the sale, the chief executive officer now owns 154,630 shares of the company’s stock, valued at $6,185,200. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.14% of the stock is owned by corporate insiders.

A number of analysts have recently commented on PBH shares. Oppenheimer reiterated a “hold” rating on shares of Prestige Consumer Healthcare in a research note on Wednesday, June 17th. ValuEngine lowered shares of Prestige Consumer Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, May 1st. TheStreet upgraded shares of Prestige Consumer Healthcare from a “c” rating to a “b-” rating in a research report on Thursday, May 7th. CIBC boosted their target price on shares of Prestige Consumer Healthcare from $86.00 to $88.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Finally, TD Securities lowered shares of Prestige Consumer Healthcare to a “hold” rating and set a $86.00 target price for the company. in a research report on Tuesday, April 14th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the company. Prestige Consumer Healthcare presently has a consensus rating of “Hold” and an average price target of $63.29.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Recommended Story: Catch-Up Contributions

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.